Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,139.83 +60.97 (+0.75%) Bitcoin USD
62,912.14 -1,012.54 (-1.58%) CMC Crypto 200
1,304.48 -92.06 (-6.59%)
bioAffinity Technologies, Inc. (BIAF)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
| Previous close | 2.4100 |
| Open | 2.3200 |
| Bid | 2.3500 x 100 |
| Ask | 2.4500 x 100 |
| Day's range | 2.3200 - 2.4299 |
| 52-week range | 0.9550 - 3.6200 |
| Volume | |
| Avg. volume | 230,109 |
| Market cap | 27.289M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9100 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Business WirebioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth
SAN ANTONIO, April 24, 2024--bioAffinity Technologies is developing diagnostics based on its proprietary platform for use with BAL fluid to detect lung cancer and to detect COPD.
Business WirebioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
SAN ANTONIO, April 09, 2024--bioAffinity Technologies and the American Cancer Society are expanding their campaign to raise funds for lung cancer screening.
Business WirebioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
SAN ANTONIO, April 01, 2024--bioAffinity Technologies reports fourth quarter and full year 2023 financial results.
© 2024 Yahoo. All rights reserved.